VASCULAR CLOSURE SYSTEM MARKET

INTRODUCTION

Angiography is now one of the most often done procedures in a variety of disciplines, including diagnostic and interventional cardiology, vascular surgery, and interventional radiology. Manual compression, the gold standard, has traditionally been used to produce hemostasis at the access site.

However, a broad range of vascular access closure devices have been developed to help the procedure list achieve hemostasis. 

These devices can be beneficial for patients with big body habitus, those on anticoagulant and antiplatelet treatment, or when prolonged bed rest is inappropriate, as in the case of a patient with significant pressure ulcers.

This exercise discusses the indications and contraindications for vascular closure devices, the procedures involved in their usage, and the role of the interprofessional team in the treatment of angiography patients.

Minimally invasive procedures are evolving in various surgical disciplines, including vascular surgery. Angiography is one of the most often done procedures in today's medical disciplines, including diagnostic and interventional cardiology, vascular surgery, and interventional radiology. Manual compression has traditionally been used to achieve hemostasis at the access site for these operations. 

While manual compression is the gold standard in this area, a variety of vascular access closure devices have been created to assist the proceduralist in accomplishing that aim.

These devices can be effective in the setting of a big body habitus, anticoagulant and antiplatelet medication, and conditions where protracted bedrest is not ideal (for example, a patient with significant pressure ulcers).

In the first two cases, manual compression must be done for a lengthy period of time or with great force. Hematoma and pseudoaneurysm development are two complications that might occur as a result of insufficient manual compression.

According to research, using these devices is safe even when patients have had thrombolytic treatment. When a 6F catheter or bigger sheath is utilized for an arterial operation, normally use vascular access closure devices.

Suture-mediated closure devices, mechanical non-suture closure devices, intra-vascular sealant devices, extra-vascular sealant devices, and manual compression aid devices are the different types of vascular access closure devices. 

These closure devices are intended for use in closing the access point to the common femoral artery. The common femoral artery becomes the external iliac artery after passing through the inguinal ligament and supplies blood to the lower extremities.

The profunda femoris and superficial femoral arteries branch off the common femoral artery. The superficial femoral artery continues as the popliteal artery into the adductor canal before splitting into the tibial arteries below the knee.

For the operation, both groins should be prepared and draped. Before beginning the operation, normally prescribe a thorough pulse exam of the lower extremity to establish a baseline for comparison and confirm that it does not alter after the vascular access closure device is applied. The position of the pedal signals is indicated with a pen using a Doppler gadget.

Some general principles should be followed for all vascular access closure devices. In addition to anatomic landmark assessment and fluoroscopic guidance, the common femoral artery should be accessible under ultrasonographic guidance.

For first access, a micro puncture kit should be utilized. The puncture should be made below the inguinal ligament and below the most superior portion of the femoral head to prevent reaching the femoral head.

A severely calcified section of the artery, and should avoid accessing the superficial and deep femoral arteries. After inserting the micro puncture needle and wire, normally use a scalpel to produce a tiny skin nick at the access site.

Tissues are spread down to the level of the artery using a hemostat. By removing extra tissue between the skin and the artery, this procedure aids in the insertion of the closure mechanism later on.

VASCULAR CLOSURE SYSTEM MARKET SIZE AND FORECAST

The Global Vascular Closure System Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

VASCULAR CLOSURE SYSTEM MARKET DYNAMICS

Haemon tics Corporation, a worldwide medical technology business committed to delivering innovative medical solutions to improve patient outcomes, announced today that its VASCADE vascular closure and VASCADE MVP venous vascular closure systems have received CE mark certification.

The CE marking will enable Haemon tics to proceed with country-specific entry of both products into the European Union (EU) and will serve as the foundation for entry into other geographies that recognize CE marking.

The VASCADE system is intended for small-bore femoral arterial and venous closure in interventional cardiology and peripheral vascular treatments.

The VASCADE MVP system is the only FDA-approved closure device for use during cardiac ablation treatments. It is designed for mid-bore multi-access femoral venous closure, which is commonly utilized in electrophysiological procedures.

Two or more access points inside the same limb are required. To achieve hemostasis, both devices use patented collapsible disc technology and a resorbable collagen patch. CASCADE and CASCADE MVP are intended to save hospital staff time while assisting patients in reaching hemostasis sooner and with fewer problems on average.

VASCADE MVP was the first and only vascular closure device to be approved by the FDA for same-day discharge after atrial fibrillation (AF) ablation. While not all EU nations are allowed to provide patients with same-day release, all patients can benefit from the faster time to ambulation and less pain that this product delivers. The VASCADE product line has resulted in great development for Haemon tics Hospital business.

THIS VASCULAR CLOSER SYSTEM MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many  Vascular Closure Systems   are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Vascular Closure System   and key vendor selection criteria
3. Where is the Vascular Closure System  manufactured? What is the average margin per unit?
4. Market share of Global Vascular Closure System   market  manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Vascular Closure System   in-house
6. 5 key predictions for next 5 years in Global Vascular Closure System   market
7. Average B-2-B  Vascular Closure System market price in all segments
8. Latest trends in  Vascular Closure System market, by every market segment
9. The market size (both volume and value) of the  Vascular Closure System   market in 2024-2030 and every year in between?
10. Production breakup of  Vascular Closure System   market, by suppliers and their OEM relationship